Routine Biopsy May Be Key to Catching Lupus Nephritis Early - European Medical Journal Routine Biopsy May Be Key to Catching Lupus Nephritis Early - AMJ

Routine Biopsy May Be Key to Catching Lupus Nephritis Early

LUPUS nephritis recurrence after kidney transplant may occur silently and more frequently than previously recognized, according to a new multisite retrospective study using both surveillance and indication biopsies.

In this analysis of 209 patients with prior lupus nephritis who received a first kidney transplant, 112 had biopsy material suitable for detailed histologic assessment. Among these, recurrent lupus nephritis (RLN) was identified in 35.7% of cases. The study distinguished between histologic recurrence (HRLN) and clinical recurrence (CRLN), with 40% and 60% of RLN cases falling into these categories, respectively.

African American patients had the highest recurrence rate, with nearly half (48.3%) experiencing RLN. Of these, half were diagnosed based on clinical signs. Notably, some cases of HRLN were identified as early as 18 days post-transplant, underscoring the value of early surveillance biopsies in detecting clinically silent disease.

Mesangioproliferative glomerular injury, aligning with class II lupus nephritis, emerged as the most common histologic pattern. IgG-dominant or codominant staining was frequently observed, while the classical “full-house” immunofluorescence pattern, traditionally associated with lupus nephritis, was present in only 6% of HRLN and 37% of CRLN cases.

C4d staining, although not used universally, prompted broader immunofluorescence testing in 37.5% of RLN patients and was supported by electron microscopy findings. The study also revealed that lupus-associated pathology accounted for half of all graft losses in RLN patients, with thrombotic microangiopathy identified in 25% of those cases.

These findings highlight the potential for RLN to progress unnoticed without routine surveillance. The authors emphasize that sequential biopsies provide critical insight into disease evolution post-transplant and suggest a potential role for expanded monitoring strategies in high-risk populations.

Reference:
Gonzalez Suarez ML et al. The Clinicopathologic Characteristics of Recurrent Lupus Nephritis Post-Transplant Using Surveillance and Indication Biopsies. Kidney Int Rep. 2025;10(6):1829-1842.

Author:

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.